The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National ...
Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
COPDは、高齢者にみられる疾患で、息切れ（呼吸困難）が主徴であり、咳を伴うことがあり、ときに少量の痰を伴うこともある。病変は年余にわたり緩徐に進行するだけに、患者は長期にわたる息苦しさに悩まされる疾患である。患者は例外なく慢性喫煙者で ...
Over 12.5 million Americans live with a lung condition known as chronic obstructive pulmonary disease (COPD), according to the American Lung Association. While COPD notably occurs in smokers, some ...
Verona Pharma's ensifentrine is a first-in-class, inhaled, dual inhibitor of the enzymes PDE3 and PDE4, targeting both bronchodilation and inflammation. Positive Phase 3 results from the ENHANCE ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する